Prostate Screening: What to Expect From PSA and DRE
Screening aims to catch prostate cancer early, but it's not without controversy. Understanding the tools, their limits, and the decision-making process helps you have an informed conversation with your provider.
The PSA blood test basics
PSA (prostate-specific antigen) is a protein produced by the prostate. Elevated levels can indicate cancer, but also BPH, prostatitis, or recent ejaculation. It's not a definitive cancer test.
The digital rectal exam (DRE)
The doctor inserts a gloved, lubricated finger into the rectum to feel the prostate's size, shape, and texture. It's brief, may be uncomfortable, but provides valuable tactile information.
Current screening guidelines vary
Major organizations differ on starting age and frequency. Most suggest shared decision-making starting at 50 (45 for higher risk). Discuss personal risk factors with your doctor.
Supplements and PSA levels
Some supplements may affect PSA readings. If you take ProstaVive or similar products, inform your doctor before testing; our review notes this: our ProstaVive review. Transparency ensures accurate interpretation.
Frequently asked questions
Does a high PSA mean I have cancer?
No. Only about 25% of men with elevated PSA have cancer on biopsy. Many other factors raise PSA.
Can I refuse the DRE and just do PSA?
You can, but the DRE adds information, especially for detecting cancers that don't raise PSA. Most urologists recommend both for a complete picture.
For a detailed look at one popular option, see our ProstaVive review.